Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esra Zerdali

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Hepatology|April 17, 2023
Investigation of liver fibrosis with serum biochemical parameters before treatment with direct-acting antivirals, at the end of treatment, and in the first and third year after treatment in patients with chronic hepatitis CMediha Bozkurt, Esra Zerdali, Filiz Pehlivanoğlu
Gynecology and Minimally Invasive Therapy|March 22, 2021
Female Genital Tuberculosis: Five Case ReportsAbdurrahman Kaya, Sibel Yildiz Kaya, Esra Zerdali, et al.
African Health Sciences|March 14, 2022
Hepatitis B virus prevalence, immunization and immune response in people living with HIV/AIDS in Istanbul, Turkey: a 21-year data analysisEsra Zerdali, Inci Yilmaz Nakir, Serkan Surme, et al.
Antibiotics (Basel, Switzerland)|May 27, 2026
Clinical Determinants of 30-Day Mortality in Candidemia: Antifungal Susceptibility and Treatment Patterns in a 10-Year Cohortİnci Yılmaz Nakir, Esra Zerdali, Selen Aksu, et al.
Journal of Infection and Public Health|May 2, 2026
Toxoplasma Gondii IGG seroprevalence among individuals living with HIV: An 18-year single-center retrospective evaluationİnci Yılmaz Nakir, Merve Kılıç Tekin, Merve Aydın, et al.
International Journal of STD & AIDS|December 22, 2025
Predictors of early mortality in Human Immunodeficiency Virus (HIV)-tuberculosis co-infectionMelike Nur Ozcelik, Esra Zerdali, Inci Yilmaz Nakir, et al.
African Health Sciences|February 28, 2022
Predictors for tuberculosis co-infection in people living with HIV/AIDsEsra Zerdali, İnci Yılmaz Nakir, Serkan Sürme, et al.
Current HIV Research|January 11, 2023
Epidemiological and Clinical Profile of Newly Diagnosed HIV/AIDS Patients: A Retrospective Analysis of Changing Trends Over 16 YearsEsra Zerdali, Inci Yilmaz Nakir, Uğurcan Sayili, et al.
Journal of Clinical Medicine|June 26, 2026
Has the Expected Shift in HIV-Related Cancers Occurred? Findings from a Long-Term HIV Cohort in Turkeyİnci Yılmaz Nakir, Melike Nur Özçelik, Rumeysa Gülistan Karaduman, et al.
Viruses|November 27, 2025
Real-World Effectiveness of Antiviral Prophylaxis for Preventing Hepatitis B Virus (HBV) Reactivation in Patients Undergoing Immunosuppressive Therapyİnci Yılmaz Nakir, Bilge Çağlar, Esra Zerdali, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Hepatology|April 17, 2023
Investigation of liver fibrosis with serum biochemical parameters before treatment with direct-acting antivirals, at the end of treatment, and in the first and third year after treatment in patients with chronic hepatitis CMediha Bozkurt, Esra Zerdali, Filiz Pehlivanoğlu
Gynecology and Minimally Invasive Therapy|March 22, 2021
Female Genital Tuberculosis: Five Case ReportsAbdurrahman Kaya, Sibel Yildiz Kaya, Esra Zerdali, et al.
African Health Sciences|March 14, 2022
Hepatitis B virus prevalence, immunization and immune response in people living with HIV/AIDS in Istanbul, Turkey: a 21-year data analysisEsra Zerdali, Inci Yilmaz Nakir, Serkan Surme, et al.
Antibiotics (Basel, Switzerland)|May 27, 2026
Clinical Determinants of 30-Day Mortality in Candidemia: Antifungal Susceptibility and Treatment Patterns in a 10-Year Cohortİnci Yılmaz Nakir, Esra Zerdali, Selen Aksu, et al.
Journal of Infection and Public Health|May 2, 2026
Toxoplasma Gondii IGG seroprevalence among individuals living with HIV: An 18-year single-center retrospective evaluationİnci Yılmaz Nakir, Merve Kılıç Tekin, Merve Aydın, et al.
International Journal of STD & AIDS|December 22, 2025
Predictors of early mortality in Human Immunodeficiency Virus (HIV)-tuberculosis co-infectionMelike Nur Ozcelik, Esra Zerdali, Inci Yilmaz Nakir, et al.
African Health Sciences|February 28, 2022
Predictors for tuberculosis co-infection in people living with HIV/AIDsEsra Zerdali, İnci Yılmaz Nakir, Serkan Sürme, et al.
Current HIV Research|January 11, 2023
Epidemiological and Clinical Profile of Newly Diagnosed HIV/AIDS Patients: A Retrospective Analysis of Changing Trends Over 16 YearsEsra Zerdali, Inci Yilmaz Nakir, Uğurcan Sayili, et al.
Journal of Clinical Medicine|June 26, 2026
Has the Expected Shift in HIV-Related Cancers Occurred? Findings from a Long-Term HIV Cohort in Turkeyİnci Yılmaz Nakir, Melike Nur Özçelik, Rumeysa Gülistan Karaduman, et al.
Viruses|November 27, 2025
Real-World Effectiveness of Antiviral Prophylaxis for Preventing Hepatitis B Virus (HBV) Reactivation in Patients Undergoing Immunosuppressive Therapyİnci Yılmaz Nakir, Bilge Çağlar, Esra Zerdali, et al.
Pageof 4